AdvaMed Comments On Device Center Condition-Of-Approval Study Plans
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers should begin working with FDA to develop postmarket study protocols early in the premarket process, according to CDRH Office of Surveillance & Biometrics Director Susan Gardner